Lean Body Mass
7
0
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Effect of Collagen Peptides, in Combination With Resistance Training, on Body Composition and Muscle Strength in Untrained Men
Does Muscle Mass At Intensive Care Unit Admission Determine Mortality: the Memo Study
The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy
Lean Body Mass in Head and Neck Cancer Patients During Cisplatin-based Chemoradiation
Impact on Energy Intake by Implementing Recommended Food Texture Through Dietary Guidance
Novel Equations for Estimating Lean Body Mass in Patients With Chronic Kidney Disease
Amino Acid Usage Patterns in Daily Practice